There are currently 72 clinical trials in Naples, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including Gastroenterology Group of Naples, Collier Neurologic Specialists, Pfizer Investigational Site and Anchor Research Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
RESPONDER-HF Trial
NCT05425459
Recruiting
Multicenter, Prospective, Randomized, Sham Controlled, Double Blinded Clinical Trial, with; 1:1 randomization
Gender:
All
Ages:
40 years and above
Trial Updated:
02/05/2024
Locations: NCH Naples, Naples, Florida
Conditions: Heart Failure, Heart Failure, Diastolic
Register for Updates
Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories
NCT04469686
Recruiting
A randomized, multi-center, double-blind, three arm placebo-controlled study in male and non-pregnant, non-lactating female subjects aged 18 years to examine the safety and efficacy of two dosing regimens of hydrocortisone acetate 90 mg suppository administered with the Sephure applicator for the treatment of ulcerative colitis of the rectum.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/05/2024
Locations: GI PROs Research, Naples, Florida
Conditions: Ulcerative Proctitis
Register for Updates
Fecal Microbiota Transplant National Registry
NCT03325855
Recruiting
A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness
Gender:
All
Ages:
All
Trial Updated:
01/29/2024
Locations: GI Pros, Naples, Florida
Conditions: Fecal Microbiota Transplantation, Clostridium Difficile Infection, Gut Microbiome
Register for Updates
Abbott Ventricular Tachycardia PAS
NCT05839873
Recruiting
This post-approval study (PAS) is designed to provide continued clinical evidence to confirm the long-term safety and effectiveness of the FlexAbilityTM Ablation Catheter, Sensor EnabledTM (FlexAbility SE) for the treatment of ventricular tachycardia in a post-market environment. This is a prospective, single arm, open-label, multi-center, observational study.
Gender:
All
Ages:
7 years and above
Trial Updated:
01/22/2024
Locations: NCH Healthcare System, Naples, Florida
Conditions: Ventricular Tachycardia
Register for Updates
TRISCEND II Pivotal Trial
NCT04482062
Recruiting
Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system
Gender:
All
Ages:
18 years and above
Trial Updated:
01/12/2024
Locations: NCH Heart Institute, Naples, Florida
Conditions: Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure
Register for Updates
MitraClip REPAIR MR Study
NCT04198870
Recruiting
The objective of this randomized controlled trial (RCT) is to compare the clinical outcome of MitraClip™ device versus surgical repair in patients with severe primary MR who are at moderate surgical risk and whose mitral valve has been determined to be suitable for correction by MV repair surgery by the cardiac surgeon on the local site heart team.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/14/2023
Locations: NCH Healthcare System, Naples, Florida
Conditions: Mitral Valve Regurgitation
Register for Updates
A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
NCT05662241
Recruiting
This study aims to examine the efficacy and safety of obexelimab for the prevention of flare of IgG4-related disease (IgG4-RD)
Gender:
All
Ages:
18 years and above
Trial Updated:
12/08/2023
Locations: GI PROS Research - Dedicated Research Facility, Naples, Florida
Conditions: IgG4 Related Disease
Register for Updates
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
NCT03821129
Recruiting
This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of trial experience to a post-market setting.
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
11/06/2023
Locations: Naples Community Hospital, Naples, Florida
Conditions: Stroke, PFO - Patent Foramen Ovale
Register for Updates
A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor
NCT05366751
Recruiting
The primary purpose of this study is to evaluate the long-term safety and tolerability of SAGE-324 in participants with essential tremor (ET).
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
09/28/2023
Locations: Sage Investigational Site, Naples, Florida
Conditions: Essential Tremor
Register for Updates
Ceribell Delirium Data Collection Study
NCT04962815
Recruiting
This study is designed as a prospective, non-randomized, observational clinical study. The study will collect clinical and rrEEG (Ceribell EEG) data when monitoring subjects for delirium subtypes. EEG and clinical data will be collected for the development of future software algorithms to assess the presence and severity of delirium.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/22/2023
Locations: Naples Community Hospital, Naples, Florida
Conditions: Delirium
Register for Updates
Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)
NCT04502316
Recruiting
The purpose of this registry is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients with heart failure with reduced ejection fraction (HFrEF) that were recently implanted with the Barostim System.
Gender:
All
Ages:
All
Trial Updated:
01/21/2023
Locations: Naples Heart Rhythm Specialists, PA, Naples, Florida
Conditions: Heart Failure
Register for Updates
Safety & Effectiveness of TENS Weight Management Compared to a Sham
NCT05675384
Recruiting
This is a multicenter, randomized, blinded, parallel group, controlled study intended to evaluate the safety and effectiveness of treating overweight and Class 1 obese patients with the Elira System (TENS active treatment) combined with a moderate intensity lifestyle follow-up compared to participants using the sham (control) device combined with a moderate intensity lifestyle follow-up
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
01/06/2023
Locations: Advanced Research for Health Improvement, LLC (ARHI), Naples, Florida
Conditions: Obesity, Mild
Register for Updates